Grit Biotechnology Competitors and Similar CompaniesClear all

Grit Biotechnology's competitors and similar companies include Quince Therapeutics Italy, Arvinas, AbCellera Biologics and Maze Therapeutics.

	Grit Biotechnology Grit Biotechnology (上海沙砾生物科技有限公司, also known as Shanghai Shashi Biotechnology) is a cell therapy company developing tumor-infiltrating lymphocyte (TIL) therapies for the treatment of solid tumors.	Quince Therapeutics Italy Quince Therapeutics Italy (formerly known as Erydel) is a company that develops technology for the drug delivery of pharmacological agents through red blood cells.	Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.	AbCellera Biologics AbCellera Biologics is a provider of an AI-powered drug discovery platform for antibody therapies.	Maze Therapeutics Maze Therapeutics is a clinical-stage biopharmaceutical company.
Founding Date	Founding Date 2019	Founding Date 2007	Founding Date N/A	Founding Date 2012	Founding Date 2018
Type	Type Private	Type Subsidiary	Type Public	Type Public	Type Public
Tags	Tags Technology drug development platform therapy	Tags Healthcare Technology biotech drug development pharma platform therapy	Tags Healthcare Technology drug development oncology pharma platform therapy	Tags Technology artificial intelligence biotech drug development platform therapy	Tags Technology biotech drug development genetics pharma platform therapy
Locations	Locations Shanghai, CN HQ Suzhou, CN	Locations Bresso, IT HQ Tre Torri, IT	Locations New Haven, US HQ	Locations Vancouver, CA HQ	Locations South San Francisco, US HQ Redwood City, US South San Francisco, US
Employees	Employees 12	Employees 19	Employees 13329% increase	Employees 596	Employees 121
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 1.9 b	Valuation ($) 833.9 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $262.6m (FY, 2025)	Revenue (est.) $75.1m (FY, 2025)	Revenue (est.) N/A
Net income	Net income N/A	Net income N/A	Net income ($80.8m) (FY, 2025)	Net income ($146.4m) (FY, 2025)	Net income ($131.1m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 60m	Total funding raised $ 35.6m	Total funding raised $ 111.6m	Total funding raised $ 115m	Total funding raised $ 191m

For sources of this data, please see the company profile

View Company Profiles

Quince Therapeutics Italy

Bresso, IT

Quince Therapeutics Italy (formerly known as Erydel) is a company that develops technology for the drug delivery of pharmacological agents through red blood cells.

View company

Arvinas

New Haven, US

Employees

133↑ 29% increase

Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.

View company

AbCellera Biologics

Vancouver, CA

Employees

596

AbCellera Biologics is a provider of an AI-powered drug discovery platform for antibody therapies.